Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human Therapies

12 Jun 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Muscle Physiology and Disorders
Share to Tissue Engineering and Regenerative Medicine
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22692496
DOI: 10.1038/mt.2012.111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human TherapiesPMID 22692496Read ↗

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophySemantic proximity Read ↗

Gene Therapy in Large Animal Models of Muscular DystrophySemantic proximity Read ↗

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy MuscleSemantic proximity Read ↗

Systemic Delivery of Allogenic Muscle Stem Cells Induces Long-Term Muscle Repair and Clinical Efficacy in Duchenne Muscular Dystrophy DogsSemantic proximity Read ↗

A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in DogsSemantic proximity Read ↗

Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical TrialsSemantic proximity Read ↗

Systemic Treatment of Body-Wide Duchenne Muscular Dystrophy Symptoms.Semantic proximity Read ↗

Canine models of Duchenne muscular dystrophy and their use in therapeutic strategiesSemantic proximity Read ↗

mRNA-Based Solution for 47, 48, 51, and 52 Dystrophin Exon Deletions: DMD Patient-Donate Primer Cells (In Vitro) and Transgenic Mice Experimental Study (In Vivo)Semantic proximity Read ↗

Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne PatientsSemantic proximity Read ↗

AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathySemantic proximity Read ↗

Generation of a dystrophin mutant dog by nuclear transfer using CRISPR/Cas9-mediated somatic cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.